1. 输入关键词后点击检索按钮可查询指定关键词在语料中的对应情况
  2. 选择语种可限定关键词的语言,当前支持中文和英文,默认选择中文
  3. 主题选项中可限定检索语料的文章主题范围,默认全部主题
  4. 主题选项中可限定检索语料的文本类型范围,默认全部类型
  5. 在结果列表中,点击操作栏中的“查看中文全文”或“查看英文全文”按钮可查看该句所在的中文语料全文
句对齐列表 共 16269 个结果  
序号 中文 英文 操作
12791 世卫组织总干事谭德塞博士说,“这是朝确保最需要的人能够获得这种救命疫苗迈出的历史性一步 “This is a historic step towards ensuring the people who most need it are able to access this life-saving vaccine," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.
12792 五年前,我们没有埃博拉疫苗,也缺乏治疗手段 "Five years ago, we had no vaccine and no therapeutics for Ebola.
12793 现在有了预认证的疫苗和实验疗法,我们就可以预防和治疗埃博拉”。 With a prequalified vaccine and experimental therapeutics, Ebola is now preventable and treatable."
12794 Ervebo是默克公司生产的埃博拉注射疫苗(在美国和加拿大以外称为MSD)。 The injectable Ebola vaccine, Ervebo, is manufactured by Merck (known as MSD outside the US and Canada).
12795 经证明,它能有效预防扎伊尔型埃博拉病毒,是世卫组织疫苗战略咨询专家组(SAGE)推荐的较广泛的埃博拉应对工具中的一项工具。 It has been shown to be effective in protecting people from the Ebola Zaire virus and is recommended by the WHO Strategic Advisory Group of Experts (SAGE) for vaccines as part of a broader set of Ebola response tools.
12796 这一决定是朝今后增加此疫苗供应方向迈出的一步,但要到2020年年中才能获得此疫苗。 The decision is a step towards greater availability of the vaccine in the future, though licensed doses will only be available mid-2020.
12797 世卫组织在欧盟委员会根据欧洲药品管理局(EMA)的建议决定给予此疫苗有条件销售授权后不到48小时内发布了预认证消息 This announcement comes less than 48 hours after the European Commission decision to grant a conditional marketing authorization for the vaccine, following the recommendation from the European Medicines Agency (EMA).
12798 公共卫生界迫切需要预认证的埃博拉疫苗。 Due to the urgent public health need for a prequalified Ebola vaccine, WHO accelerated prequalification by reviewing safety and efficacy data as the information became available.
12799 世卫组织在获得信息后,加快了预认证工作,审查了安全和功效数据。 Representatives from the prequalification team participated in the EMA evaluation process to address programmatic suitability for at-risk countries in Africa.
12800 谭德塞博士指出,“这一疫苗的开发、研究和快速预认证表明,随着我们重视弱势人群的健康需求,国际社会可以大有作为”。 "The development, study, and rapid prequalification of this vaccine show what the global community can do when we prioritize the health needs of vulnerable people,” said Dr Tedros.